BACKGROUND AND AIMS: Endoscopic papillectomy is a safe and effective treatment for ampullary adenomas and has mostly replaced surgical local resection. Recent data have discussed the role of endoscopic removal of laterally spreading adenomas associated with ampullary adenomas. We evaluated our long-term results of endoscopic papillectomy for ampullary adenomas. METHODS: We retrospectively analyzed patients who underwent endoscopic papillectomy of biopsy-proven adenomas at our tertiary center between 1994 and 2017. Clinical success was defined as complete excision of an adenoma with no evidence of recurrence during follow-up, no evidence of cancer, and without the need for surgery. RESULTS: A total of 161 patients (73M/88F) with a mean age of 61 (range 19-93) were included. Mean adenoma size was 20 mm (range 5-70). In total, 114/161 patients continued endoscopic surveillance for a minimum of 6 months with a median follow-up of 30 months (range 6-283). Recurrent adenomas were diagnosed in 8 patients (7%) after a median of 36 months (range 12-138). Clinical success was 83%; 35 laterally spreading adenomas were treated, which were larger than adenomas confined to the papilla (mean size 38 mm vs 15 mm, P < 0.05) and required more piecemeal resections (77% vs 15%, P < 0.05). However, no difference was found in recurrence rates between the two groups (8% vs 4%, P = 0.26); 24/161 (15%) of patients had adverse events including bleeding (6%) and pancreatitis (7%). CONCLUSIONS: Endoscopic papillectomy is a safe and effective treatment for ampullary adenomas, including laterally spreading ones. Long-term surveillance demonstrates low recurrence rates at expert centers.
BACKGROUND AND AIMS: Endoscopic papillectomy is a safe and effective treatment for ampullary adenomas and has mostly replaced surgical local resection. Recent data have discussed the role of endoscopic removal of laterally spreading adenomas associated with ampullary adenomas. We evaluated our long-term results of endoscopic papillectomy for ampullary adenomas. METHODS: We retrospectively analyzed patients who underwent endoscopic papillectomy of biopsy-proven adenomas at our tertiary center between 1994 and 2017. Clinical success was defined as complete excision of an adenoma with no evidence of recurrence during follow-up, no evidence of cancer, and without the need for surgery. RESULTS: A total of 161 patients (73M/88F) with a mean age of 61 (range 19-93) were included. Mean adenoma size was 20 mm (range 5-70). In total, 114/161 patients continued endoscopic surveillance for a minimum of 6 months with a median follow-up of 30 months (range 6-283). Recurrent adenomas were diagnosed in 8 patients (7%) after a median of 36 months (range 12-138). Clinical success was 83%; 35 laterally spreading adenomas were treated, which were larger than adenomas confined to the papilla (mean size 38 mm vs 15 mm, P < 0.05) and required more piecemeal resections (77% vs 15%, P < 0.05). However, no difference was found in recurrence rates between the two groups (8% vs 4%, P = 0.26); 24/161 (15%) of patients had adverse events including bleeding (6%) and pancreatitis (7%). CONCLUSIONS: Endoscopic papillectomy is a safe and effective treatment for ampullary adenomas, including laterally spreading ones. Long-term surveillance demonstrates low recurrence rates at expert centers.
Authors: John R Hornick; Fabian M Johnston; Peter O Simon; Morgan Younkin; Michael Chamberlin; Jonathan B Mitchem; Riad R Azar; David C Linehan; Steven M Strasberg; Steven A Edmundowicz; William G Hawkins Journal: Surgery Date: 2011-08 Impact factor: 3.982
Authors: Chi-Liang Cheng; Stuart Sherman; Evan L Fogel; Lee McHenry; James L Watkins; Toyomi Fukushima; Thomas J Howard; Laura Lazzell-Pannell; Glen A Lehman Journal: Gastrointest Endosc Date: 2004-11 Impact factor: 9.427
Authors: Wiriyaporn Ridtitid; Damien Tan; Suzette E Schmidt; Evan L Fogel; Lee McHenry; James L Watkins; Glen A Lehman; Stuart Sherman; Gregory A Coté Journal: Gastrointest Endosc Date: 2013-10-01 Impact factor: 9.427
Authors: Amir Klein; Zhengyan Qi; Farzan F Bahin; Halim Awadie; Dhruv Nayyar; Michael Ma; Rogier P Voermans; Stephen J Williams; Eric Lee; Michael J Bourke Journal: Endoscopy Date: 2018-05-16 Impact factor: 10.093
Authors: Edwin O Onkendi; Nimesh D Naik; Jordan K Rosedahl; Scott W Harmsen; Christopher J Gostout; Todd H Baron; Michael G Sarr; Florencia G Que Journal: J Gastrointest Surg Date: 2014-06-11 Impact factor: 3.452
Authors: Seong Ji Choi; Hong Sik Lee; Jiyeong Kim; Jung Wan Choe; Jae Min Lee; Jong Jin Hyun; Jai Hoon Yoon; Hyo Jung Kim; Jae Seon Kim; Ho Soon Choi Journal: World J Gastroenterol Date: 2022-05-07 Impact factor: 5.374
Authors: Jeska A Fritzsche; Amir Klein; Maarten J Beekman; Jeanin E van Hooft; Mayenaaz Sidhu; Scott Schoeman; Paul Fockens; Michael J Bourke; Rogier P Voermans Journal: Surg Endosc Date: 2020-11-06 Impact factor: 4.584
Authors: Jeska A Fritzsche; Paul Fockens; Marc Barthet; Marco J Bruno; David L Carr-Locke; Guido Costamagna; Gregory A Coté; Pierre H Deprez; Marc Giovannini; Gregory B Haber; Robert H Hawes; Jong Jin Hyun; Takao Itoi; Eisuke Iwasaki; Leena Kylänpaä; Horst Neuhaus; Jeong Youp Park; D Nageshwar Reddy; Arata Sakai; Michael J Bourke; Rogier P Voermans Journal: Gastrointest Endosc Date: 2021-04-19 Impact factor: 9.427